BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16111465)

  • 1. Antiangiogenic strategies in hepatocellular carcinoma: current status.
    Zacharoulis D; Hatzitheofilou C; Athanasiou E; Zacharoulis S
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):645-56. PubMed ID: 16111465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and anti-angiogenesis in hepatocellular carcinoma.
    Ribatti D; Vacca A; Nico B; Sansonno D; Dammacco F
    Cancer Treat Rev; 2006 Oct; 32(6):437-44. PubMed ID: 16870349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting vessels to treat hepatocellular carcinoma.
    Romanque P; Piguet AC; Dufour JF
    Clin Sci (Lond); 2008 Apr; 114(7):467-77. PubMed ID: 18302534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategy of antiangiogenic therapy for hepatocellular carcinoma.
    Wu XZ
    Neoplasma; 2008; 55(6):472-81. PubMed ID: 18999874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis blockade as therapy for hepatocellular carcinoma: progress and challenges.
    Hao CY
    J Gastroenterol Hepatol; 2011 Jan; 26(1):4-6. PubMed ID: 21175786
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular changes in hepatocellular carcinoma.
    Yang ZF; Poon RT
    Anat Rec (Hoboken); 2008 Jun; 291(6):721-34. PubMed ID: 18484619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature.
    Kaseb AO; Hanbali A; Cotant M; Hassan MM; Wollner I; Philip PA
    Cancer; 2009 Nov; 115(21):4895-906. PubMed ID: 19637355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.
    Pang R; Poon RT
    Cancer Lett; 2006 Oct; 242(2):151-67. PubMed ID: 16564617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approaches to the diagnosis and management of hepatocellular carcinoma.
    Perry JF; Poustchi H; George J; Farrell GC; McCaughan GW; Strasser SI
    Clin Exp Med; 2005 May; 5(1):1-13. PubMed ID: 15928877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma.
    Wu XZ; Xie GR; Chen D
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1178-82. PubMed ID: 17559361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with inhibitors of angiogenesis in advanced hepatocellular carcinoma: a new tool in our hands or simply a hope?
    Cipriani G; Mazzanti R
    Dig Liver Dis; 2005 Apr; 37(4):230-1. PubMed ID: 15788205
    [No Abstract]   [Full Text] [Related]  

  • 12. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW; Poon RT
    Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials of antiangiogenic therapy for hepatocellular carcinoma.
    Taketomi A
    Int J Clin Oncol; 2016 Apr; 21(2):213-218. PubMed ID: 26899258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular structure and abnormal expression of angiopoietin-2 and antiangiogenic targeting therapy of hepatocelluar carcinoma].
    GU WJ; YAO DF
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):398-400. PubMed ID: 19497214
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular targeted therapies in hepatocellular carcinoma.
    Tanaka S; Arii S
    Semin Oncol; 2012 Aug; 39(4):486-92. PubMed ID: 22846865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecularly targeted therapy in hepatocellular carcinoma.
    Huynh H
    Biochem Pharmacol; 2010 Sep; 80(5):550-60. PubMed ID: 20371362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypoxia in hepatocellular carcinoma].
    Myung SJ; Yoon JH
    Korean J Hepatol; 2007 Mar; 13(1):9-19. PubMed ID: 17380070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy of hepatocellular carcinoma: present and future.
    Chan SL; Yeo W
    J Gastroenterol Hepatol; 2012 May; 27(5):862-72. PubMed ID: 22369685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?
    Abou-Alfa GK; Venook AP
    Lancet Oncol; 2013 Jun; 14(7):e283-8. PubMed ID: 23725711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.
    Tanaka S; Arii S
    Int J Clin Oncol; 2006 Apr; 11(2):82-9. PubMed ID: 16622743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.